3 Patents
- US122029042025IL-23R Antagonists to Reprogram Intratumoral T Regulatory Cells Into Effector Cells
DANA-FARBER CANCER INSTITUTE, Inc.
0 cites - US115902132023Targeted Expansion of Qa-1-peptide-specific Regulatory CD8 T Cells to Ameliorate Arthritis
DANA-FARBER CANCER INSTITUTE, Inc.
0 cites - US115914032023IL-23R Antagonists to Reprogram Intratumoral T Regulatory Cells Into Effector Cells
Dana-farber Cancer Institute, Inc.
0 cites